We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Ninth Circuit Remands Royalty Dispute Over Zilactin

Law360 (September 5, 2007, 12:00 AM EDT) -- A federal appeals court has ruled that a lower court overstepped its bounds by determining that an agreement over royalties for a patent covering a herpes treatment was unenforceable.

The U.S. Court of Appeals for the Ninth Circuit on Wednesday found that the U.S. District Court for the District of Nevada wrongly applied a prior ruling by the Supreme Court to allow a patent holding company to stop making royalty payments to the inventor of the original patent of Zilactin, a liquid solution to treat herpes....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.